AU2002349352A1 - Keratinocytes which may be used as biologically active substances for the treatment of wounds - Google Patents

Keratinocytes which may be used as biologically active substances for the treatment of wounds

Info

Publication number: AU2002349352A1
Authority: AU; Australia
Prior art keywords: keratinocytes; wounds; treatment; biologically active; active substances
Prior art date: 2001-10-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002349352A

Other versions

AU2002349352B2 (en

Inventor

Petra Eberhardt

Wolfgang Noe

Katharina Reif

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-17

Filing date

2002-10-14

Publication date

2003-07-03

2001-10-17 Priority claimed from DE10151296A external-priority patent/DE10151296A1/en

2002-10-14 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2003-07-03 Publication of AU2002349352A1 publication Critical patent/AU2002349352A1/en

2007-11-01 Application granted granted Critical

2007-11-01 Publication of AU2002349352B2 publication Critical patent/AU2002349352B2/en

2022-10-14 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002349352A 2001-10-17 2002-10-14 Keratinocytes which may be used as biologically active substances for the treatment of wounds Ceased AU2002349352B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10151296A DE10151296A1 (en)	2001-10-17	2001-10-17	Keratinocytes useful as a biologically active substance in the treatment of wounds
DE10151296.1		2001-10-17
PCT/EP2002/011459 WO2003033686A2 (en)	2001-10-17	2002-10-14	Keratinocytes which may be used as biologically active substances for the treatment of wounds

Publications (2)

Publication Number	Publication Date
AU2002349352A1 true AU2002349352A1 (en)	2003-07-03
AU2002349352B2 AU2002349352B2 (en)	2007-11-01

Family

ID=7702826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002349352A Ceased AU2002349352B2 (en)	2001-10-17	2002-10-14	Keratinocytes which may be used as biologically active substances for the treatment of wounds

Country Status (30)

Country	Link
US (3)	US7247478B2 (en)
EP (1)	EP1440148B1 (en)
JP (1)	JP4476625B2 (en)
KR (1)	KR101019916B1 (en)
CN (1)	CN100432220C (en)
AR (1)	AR036827A1 (en)
AT (1)	ATE474039T1 (en)
AU (1)	AU2002349352B2 (en)
BR (1)	BR0213282A (en)
CA (1)	CA2461141C (en)
CO (1)	CO5580844A2 (en)
DE (2)	DE10151296A1 (en)
DK (1)	DK1440148T3 (en)
EA (1)	EA009073B1 (en)
EC (1)	ECSP045065A (en)
ES (1)	ES2345767T3 (en)
HR (1)	HRP20040347B1 (en)
HU (1)	HU228887B1 (en)
IL (2)	IL161442A0 (en)
MX (1)	MXPA04003487A (en)
MY (1)	MY137828A (en)
NO (1)	NO334974B1 (en)
NZ (1)	NZ532899A (en)
PE (1)	PE20030627A1 (en)
PL (1)	PL367338A1 (en)
RS (1)	RS30104A (en)
UA (1)	UA81398C2 (en)
UY (1)	UY27486A1 (en)
WO (1)	WO2003033686A2 (en)
ZA (1)	ZA200402306B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
JP4734245B2 (en) *	2003-08-01	2011-07-27	ストラタテックコーポレーション	Human skin equivalent expressing exogenous polypeptide
US20060019237A1 (en) *	2004-07-20	2006-01-26	The Regents Of The University Of California	In vitro wound healing assay and device
DE102004054054A1 (en)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
PE20080251A1 (en)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	USES OF DPP IV INHIBITORS
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
BRPI0711558A2 (en)	2006-05-04	2011-11-08	Boeringer Ingelheim Internat Gmbh	polymorphs
WO2009052429A1 (en) *	2007-10-19	2009-04-23	Jarrell John D	Novel compositions and related methods, coatings, and articles
PE20091730A1 (en)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	FORMULATIONS INVOLVING A DPP4 INHIBITOR
CN102123717A (en)	2008-05-27	2011-07-13	普拉里斯坦有限公司	Methods of treating inflammatory colon diseases
UY32030A (en)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN"
KR20190016601A (en)	2008-08-06	2019-02-18	베링거 인겔하임 인터내셔날 게엠베하	Treatment for diabetes in patients inappropriate for metformin therapy
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en)	2008-12-23	2015-09-03	Boehringer Ingelheim International Gmbh	Salt forms of organic compound
AR074990A1 (en)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	TREATMENT OF DIABETES IN PATIENTS WITH AN INAPPROPRIATE GLUCEMIC CONTROL THROUGH METFORMIN THERAPY
PH12012501037A1 (en)	2009-11-27	2013-01-14	Boehringer Ingelheim Int	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
CA2797310C (en)	2010-05-05	2020-03-31	Boehringer Ingelheim International Gmbh	Glp-1 receptor agonist and dpp-4 inhibitor combination therapy
EP2711423B1 (en) *	2010-06-09	2014-11-05	Chanel Parfums Beauté	Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
KR20230051307A (en)	2010-06-24	2023-04-17	베링거 인겔하임 인터내셔날 게엠베하	Diabetes therapy
US9034883B2 (en)	2010-11-15	2015-05-19	Boehringer Ingelheim International Gmbh	Vasoprotective and cardioprotective antidiabetic therapy
ES2713566T3 (en)	2011-07-15	2019-05-22	Boehringer Ingelheim Int	Derivative of substituted dinamic quinazoline, its preparation and its use in pharmaceutical compositions for the treatment of type I and II diabetes
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US20130303462A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (en)	2012-05-14	2023-03-22	Boehringer Ingelheim International GmbH	Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2013174769A1 (en)	2012-05-25	2013-11-28	Boehringer Ingelheim International Gmbh	Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor
EP3110449B1 (en)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medical use of a dpp-4 inhibitor
CN105219697A (en) *	2014-07-04	2016-01-06	赫柏慧康生物科技无锡有限公司	A kind of people's primary keratinocyte is separated the method for preparation
EP3132809A1 (en)	2015-08-21	2017-02-22	Bioskinco GmbH	Composition and products comprising senescent cells for use in tissue regeneration
US10668259B2 (en)	2015-10-21	2020-06-02	Materials Science Associates, LLC	Metal oxide and polymer controlled delivery systems, sunscreens, treatments, and topical coating applicators
EP3443112B1 (en) *	2016-04-12	2020-08-05	Unicyte EV AG	Isolation of extracellular vesicles (evs) from biological fluid samples
WO2017211979A1 (en)	2016-06-10	2017-12-14	Boehringer Ingelheim International Gmbh	Combinations of linagliptin and metformin
CN109055303A (en) *	2018-09-12	2018-12-21	山东麦德克斯生物科技有限公司	A kind of construction method of skin histology
RU2731065C1 (en) *	2019-12-24	2020-08-28	Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН (ИБР РАН)	Cryopreservant composition for long-term storage of primary keratinocytes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4016038A (en) *	1968-04-01	1977-04-05	Hayashibara Company	Process for preparing maltoses from starches
US4016036A (en)	1975-11-14	1977-04-05	Massachusetts Institute Of Technology	Process for serially culturing keratinocytes
IT1207525B (en)	1987-06-23	1989-05-25	Ist Naz Ric Sul Cancro	METHOD FOR THE PRESERVATION OF TRANSPLANTABLE SHEETS OF EPITELIUM CULTIVATED IN VITRO VITRO.
US5292655A (en) *	1990-01-29	1994-03-08	Wille Jr John J	Method for the formation of a histologically-complete skin substitute
IT1248934B (en) *	1990-06-01	1995-02-11	Fidia Spa	BIOCOMPATIBLE PERFORATED MEMBRANES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A SUPPORT FOR THE IN VITRO GROWTH OF EPITHELIAL CELLS, ARTIFICIAL LEATHER THUS OBTAINED AND THEIR USE IN LEATHER TRANSPLANTS
DE69233558T2 (en) *	1991-11-20	2006-07-27	Innogenetics N.V.	Keratinocyte-derived granules for use as a wound healing agent
US6585969B1 (en)	1991-11-20	2003-07-01	N. V. Innogenetics S.A.	Non-viable keratinocyte cell composition or lysate for promoting wound healing
US5518878A (en)	1993-09-15	1996-05-21	Organogenesis Inc.	Cryopreservation of cultured skin or cornea equivalents with agitation
US5891617A (en) *	1993-09-15	1999-04-06	Organogenesis Inc.	Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing
US5693332C1 (en)	1995-08-11	2001-01-09	Univ California	Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
AUPP244498A0 (en)	1998-03-18	1998-04-09	Medvet Science Pty. Ltd.	Keratinocyte stem cells
DE19917532A1 (en)	1999-04-19	2000-10-26	Christian Toloczyki	Carrier-bound keratinocyte stem or precursor cells, useful for cosmetic or therapeutic regeneration of the epidermis

2001
- 2001-10-17 DE DE10151296A patent/DE10151296A1/en not_active Withdrawn
2002
- 2002-10-10 US US10/268,496 patent/US7247478B2/en not_active Expired - Fee Related
- 2002-10-14 DE DE50214540T patent/DE50214540D1/en not_active Expired - Lifetime
- 2002-10-14 IL IL16144202A patent/IL161442A0/en unknown
- 2002-10-14 CA CA2461141A patent/CA2461141C/en not_active Expired - Fee Related
- 2002-10-14 AT AT02781248T patent/ATE474039T1/en active
- 2002-10-14 JP JP2003536415A patent/JP4476625B2/en not_active Expired - Fee Related
- 2002-10-14 HU HU0600341A patent/HU228887B1/en not_active IP Right Cessation
- 2002-10-14 AU AU2002349352A patent/AU2002349352B2/en not_active Ceased
- 2002-10-14 CN CNB028207874A patent/CN100432220C/en not_active Expired - Fee Related
- 2002-10-14 UA UA20040503620A patent/UA81398C2/en unknown
- 2002-10-14 EA EA200400482A patent/EA009073B1/en not_active IP Right Cessation
- 2002-10-14 WO PCT/EP2002/011459 patent/WO2003033686A2/en not_active Ceased
- 2002-10-14 HR HRP20040347AA patent/HRP20040347B1/en not_active IP Right Cessation
- 2002-10-14 RS YU30104A patent/RS30104A/en unknown
- 2002-10-14 NZ NZ532899A patent/NZ532899A/en not_active IP Right Cessation
- 2002-10-14 ES ES02781248T patent/ES2345767T3/en not_active Expired - Lifetime
- 2002-10-14 KR KR1020047005677A patent/KR101019916B1/en not_active Expired - Fee Related
- 2002-10-14 PL PL02367338A patent/PL367338A1/en unknown
- 2002-10-14 BR BR0213282-6A patent/BR0213282A/en not_active Application Discontinuation
- 2002-10-14 EP EP02781248A patent/EP1440148B1/en not_active Expired - Lifetime
- 2002-10-14 UY UY27486A patent/UY27486A1/en not_active Application Discontinuation
- 2002-10-14 DK DK02781248.6T patent/DK1440148T3/en active
- 2002-10-15 MY MYPI20023849A patent/MY137828A/en unknown
- 2002-10-15 PE PE2002001015A patent/PE20030627A1/en not_active Application Discontinuation
- 2002-10-16 AR ARP020103870A patent/AR036827A1/en unknown
2004
- 2004-03-24 ZA ZA200402306A patent/ZA200402306B/en unknown
- 2004-04-14 MX MXPA04003487A patent/MXPA04003487A/en active IP Right Grant
- 2004-04-15 IL IL161442A patent/IL161442A/en not_active IP Right Cessation
- 2004-04-15 EC EC2004005065A patent/ECSP045065A/en unknown
- 2004-04-16 NO NO20041570A patent/NO334974B1/en not_active IP Right Cessation
- 2004-04-16 CO CO04035176A patent/CO5580844A2/en not_active Application Discontinuation
2006
- 2006-11-03 US US11/556,367 patent/US7306943B2/en not_active Expired - Fee Related
2007
- 2007-10-31 US US11/930,880 patent/US7754481B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
AU2002349352A1 (en)	2003-07-03	Keratinocytes which may be used as biologically active substances for the treatment of wounds
HUP0600341A2 (en)	2006-08-28	Keratinocytes which may be used as biologically active substances for the treatment of wounds
AU2002342613A1 (en)	2002-11-25	Treatment for wounds
EP1425277B8 (en)	2009-04-01	Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2001272849A1 (en)	2002-01-21	Composition for the treatment of osteoarthritis
AU2000276362A1 (en)	2002-01-21	Composition for the treatment of diabetes
AU2002240359A1 (en)	2002-08-28	Pharmaceutical composition for the treatment of alopecia
AU2002213887A1 (en)	2002-03-26	Process for the antimicrobial treatment of fiber materials
AU2002315814A1 (en)	2003-05-22	Medicinal composition for treatment of interstitial cystitis
AU2002361046A1 (en)	2003-07-09	Unit for the treatment of histological samples
AU2003237969A1 (en)	2004-01-06	Pharmaceutical composition comprising calcium channel blockers for the treatment of pain
AU1878201A (en)	2001-07-16	Composition for the treatment of damaged tissue
AU2002327440A1 (en)	2003-03-10	Treatment of type i diabetes
AU2003263332A1 (en)	2004-04-30	Wound dressings for the treatment of wound infection
AU2003292882A1 (en)	2005-03-07	Thrombin from venom of agkistrodon acutus used as drugs for the treatment of haemorrhage
GB0020588D0 (en)	2000-10-11	Treatment of wounds
AU2683500A (en)	2000-09-14	Compositions for the treatment of pain
AUPR637001A0 (en)	2001-08-09	Pharmaceutical composition for the treatment of skin conditions
AUPQ902000A0 (en)	2000-08-17	Pharmaceutical composition for the treatment of skin conditions
AU2002320937A1 (en)	2003-03-10	Pharmaceutical preparation for treating wounds
AU2002327697A1 (en)	2003-04-07	Compounds for the treatment of pain
AU2002237585A1 (en)	2002-08-12	Method for the treatment of active sludges
AU7445601A (en)	2001-12-24	Pharmaceutical composition for the treatment of multiple sclerosis
AU2002325743A1 (en)	2003-03-24	Biofermentor for the treatment of biologically convertible matter
AU2002313005B2 (en)	2007-03-08	Use of glycoprotein for the treatment and re-epithelisation of wounds